-
Je něco špatně v tomto záznamu ?
EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care
PW. Hellings, I. Alobid, WT. Anselmo-Lima, M. Bernal-Sprekelsen, L. Bjermer, L. Caulley, A. Chaker, J. Constantinidis, DM. Conti, E. De Corso, M. Desrosiers, Z. Diamant, P. Gevaert, JK. Han, E. Heffler, C. Hopkins, BN. Landis, O. Lourenco, V....
Jazyk angličtina Země Dánsko
Typ dokumentu časopisecké články, přehledy, práce podpořená grantem
PubMed
38108602
DOI
10.1111/all.15982
Knihovny.cz E-zdroje
- MeSH
- chronická nemoc MeSH
- lidé MeSH
- management nemoci MeSH
- nosní polypy * terapie diagnóza MeSH
- rinosinusitida * diagnóza terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Following the European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) treatment algorithm for chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP), patients suffering from severe uncontrolled CRSwNP are recommended to receive oral corticosteroids, (revision) sinus surgery, systemic biologicals and/or aspirin treatment after desensitization (ATAD). Given the major differences in indications, outcomes, practical considerations, risks and costs of these key pillars of treatment, there is a growing need to define criteria for each treatment option and list the clinically relevant and major considerations for them. This EUFOREA document therefore provides an expert panel overview of the expected outcomes, specific considerations and (contra)indications of the five major treatment arms of severe uncontrolled CRSwNP: oral corticosteroids, primary and revision sinus surgery, biological treatment and ATAD. This overview of treatment considerations is needed to allow physicians and patients to consider the different options in the context of providing optimal and personalized care for severe uncontrolled CRSwNP. In conclusion, the five major treatment options for severe uncontrolled CRSwNP have intrinsic advantages, specific indications and considerations that are of importance to the patient, the physician and the society. This EUFOREA statement supports the unmet need to define criteria for the indication of every treatment pillar of CRSwNP.
Center of Biomedical Research in Respiratory Diseases Barcelona Spain
CICS UBI Health Sciences Research Centre University of Beira Interior Covilhã Portugal
Clinical Epidemiology Program The Ottawa Hospital Research Institute Ottawa Ontario Canada
Department of Biomedical Sciences Humanitas University Pieve Emanuele Italy
Department of General Otorhinolaryngology H and N Surgery Medical University of Graz Graz Austria
Department of ORL HNS Université de Montréal Montreal Canada
Department of Otolaryngology and Head and Neck Surgery Eastern Virginia Medical School Virginia USA
Department of Otolaryngology Head and Neck Surgery University of Ottawa Ottawa Ontario Canada
Department of Otorhinolaryngology Hospital Clinic Barcelona Barcelona Spain
Department of Otorhinolaryngology Universitätsklinikum Düsseldorf Dusseldorf Germany
Department of Otorhinolaryngology University of Barcelona Barcelona Spain
Department of Otorhinolaryngology Upper airways research laboratory Ghent University Ghent Belgium
Ear Nose and Throat Department Guys and St Thomas Hospital London UK
Faculty of Medicine and Health Sciences University of Antwerp Antwerp Belgium
FCS UBI Faculty of Health Sciences University of Beira Interior Covilhã Portugal
Institut for Klinisk Medicin Aarhus University Aarhus Denmark
Norfolk and Waveney ENT Service James Paget and Norfolk and Norwich University Hospitals Norfolk UK
Otolaryngology HNS Thomas Jefferson University Philadelphia Pennsylvania USA
Personalized Medicine Asthma and Allergy IRCCS Humanitas Research Hospital Rozzano Italy
Rhinology and ENT Research Group Norwich Medical School University of East Anglia Norwich UK
Royal National Ear Nose and Eastman Dental Hospital London UK
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24014201
- 003
- CZ-PrNML
- 005
- 20241024114127.0
- 007
- ta
- 008
- 240725s2024 dk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/all.15982 $2 doi
- 035 __
- $a (PubMed)38108602
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a dk
- 100 1_
- $a Hellings, Peter W $u Department of Microbiology and Immunology, Allergy and Clinical Immunology Research unit, KU Leuven, Leuven, Belgium $u Clinical Department of Otorhinolaryngology, Head and Neck Surgery, University Hospitals Leuven, Leuven, Belgium $u Department of Otorhinolaryngology, Upper airways research laboratory, Ghent University, Ghent, Belgium $1 https://orcid.org/000000016898688X
- 245 10
- $a EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care / $c PW. Hellings, I. Alobid, WT. Anselmo-Lima, M. Bernal-Sprekelsen, L. Bjermer, L. Caulley, A. Chaker, J. Constantinidis, DM. Conti, E. De Corso, M. Desrosiers, Z. Diamant, P. Gevaert, JK. Han, E. Heffler, C. Hopkins, BN. Landis, O. Lourenco, V. Lund, AU. Luong, J. Mullol, A. Peters, C. Philpott, S. Reitsma, D. Ryan, G. Scadding, B. Senior, PV. Tomazic, E. Toskala, T. Van Zele, AS. Viskens, M. Wagenmann, WJ. Fokkens
- 520 9_
- $a Following the European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) treatment algorithm for chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP), patients suffering from severe uncontrolled CRSwNP are recommended to receive oral corticosteroids, (revision) sinus surgery, systemic biologicals and/or aspirin treatment after desensitization (ATAD). Given the major differences in indications, outcomes, practical considerations, risks and costs of these key pillars of treatment, there is a growing need to define criteria for each treatment option and list the clinically relevant and major considerations for them. This EUFOREA document therefore provides an expert panel overview of the expected outcomes, specific considerations and (contra)indications of the five major treatment arms of severe uncontrolled CRSwNP: oral corticosteroids, primary and revision sinus surgery, biological treatment and ATAD. This overview of treatment considerations is needed to allow physicians and patients to consider the different options in the context of providing optimal and personalized care for severe uncontrolled CRSwNP. In conclusion, the five major treatment options for severe uncontrolled CRSwNP have intrinsic advantages, specific indications and considerations that are of importance to the patient, the physician and the society. This EUFOREA statement supports the unmet need to define criteria for the indication of every treatment pillar of CRSwNP.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a chronická nemoc $7 D002908
- 650 _2
- $a management nemoci $7 D019468
- 650 12
- $a nosní polypy $x terapie $x diagnóza $7 D009298
- 650 12
- $a rinosinusitida $x diagnóza $x terapie $7 D000096825
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Alobid, Isam $u Rhinology and Skull Base Unit, ENT Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain $u Clinical and Experimental Respiratory Immunoallergy, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain $u Center of Biomedical Research in Respiratory Diseases (CIBERES), Barcelona, Spain
- 700 1_
- $a Anselmo-Lima, Wilma T $u Division of Otorhinolaryngology, Department of Ophthalmology, Otorhinolaryngology, Head and Neck Surgery, Ribeirao Preto Medical School-University of Sao Paulo, Brazil
- 700 1_
- $a Bernal-Sprekelsen, Manuel $u Department of Otorhinolaryngology, University of Barcelona, Barcelona, Spain $u Department of Otorhinolaryngology, Hospital Clinic Barcelona, Barcelona, Spain $1 https://orcid.org/0000000181919833
- 700 1_
- $a Bjermer, Leif $u Department of Respiratory Medicine & Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden $1 https://orcid.org/0000000234418099
- 700 1_
- $a Caulley, Lisa $u Department of Otolaryngology-Head and Neck Surgery, University of Ottawa, Ottawa, Ontario, Canada $u Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada $u Institut for Klinisk Medicin, Aarhus University, Aarhus, Denmark
- 700 1_
- $a Chaker, Adam $u Dept. of Otorhinolaryngology and Center for Allergy and Environment (ZAUM), TUM School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany $1 https://orcid.org/0000000251174073
- 700 1_
- $a Constantinidis, Jannis $u 1st Department of Otorhinolaryngology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece $1 https://orcid.org/000000022369993X
- 700 1_
- $a Conti, Diego M $u The European Forum for Research and Education in Allergy and Airway Diseases Scientific Expert Team Members, Brussels, Belgium $1 https://orcid.org/000000028896495X
- 700 1_
- $a De Corso, Eugenio $u Otolaryngology, Head and Neck Surgery, Rhinology, A. Gemelli University Hospital Foundation, IRCSS, Rome, Italy $1 https://orcid.org/0000000157617018
- 700 1_
- $a Desrosiers, Martin $u Department of ORL-HNS, Université de Montréal, Montreal, Canada
- 700 1_
- $a Diamant, Zuzana $u Department of Respiratory Medicine & Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden $u Department of Microbiology Immunology & Transplantation, KU Leuven, Catholic University of Leuven, Leuven, Belgium $u Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic $u Department of Clinical Pharmacy & Pharmacology, University in Groningen, University Medical Center Groningen, Groningen, Netherlands $1 https://orcid.org/0000000301330100 $7 xx0138653
- 700 1_
- $a Gevaert, Philippe $u Department of Otorhinolaryngology, Upper airways research laboratory, Ghent University, Ghent, Belgium $1 https://orcid.org/0000000216298468
- 700 1_
- $a Han, Joseph K. $u Department of Otolaryngology & Head and Neck Surgery, Eastern Virginia Medical School, Virginia, USA $7 xx0324318
- 700 1_
- $a Heffler, Enrico $u Personalized Medicine, Asthma and Allergy-IRCCS Humanitas Research Hospital, Rozzano, Italy $u Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy $1 https://orcid.org/0000000204925663
- 700 1_
- $a Hopkins, Claire $u Ear, Nose and Throat Department, Guys and St. Thomas Hospital, London, UK
- 700 1_
- $a Landis, Basile N $u Rhinology-Olfactology Unit, Department of Otorhinolaryngology Head and Neck Surgery, University Hospital of Geneva, Geneva, Switzerland
- 700 1_
- $a Lourenco, Olga $u FCS-UBI, Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal $u CICS-UBI, Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal $1 https://orcid.org/0000000284015976
- 700 1_
- $a Lund, Valerie $u Royal National Ear, Nose and Eastman Dental Hospital, London, UK
- 700 1_
- $a Luong, Amber U $u Otolaryngology-HNS, McGovern Medical School of the University of Texas Health Science Center, Houston, Texas, USA $1 https://orcid.org/0000000160788010
- 700 1_
- $a Mullol, Joaquim $u Rhinology Unit and Smell Clinic, ENT Department, Hospital Clínic, FRCB-IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Spain $1 https://orcid.org/0000000334635007
- 700 1_
- $a Peters, Anju $u Division of Allergy and Immunology and Northwestern Sinus Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA $1 https://orcid.org/0000000307452379
- 700 1_
- $a Philpott, Carl $u Rhinology & ENT Research Group, Norwich Medical School, University of East Anglia, Norwich, UK $u Norfolk & Waveney ENT Service, James Paget and Norfolk & Norwich University Hospitals, Norfolk, UK $1 https://orcid.org/0000000211253236
- 700 1_
- $a Reitsma, Sietze $u Department of Otorhinolaryngology, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands $1 https://orcid.org/0000000317342632
- 700 1_
- $a Ryan, Dermot $u Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK $1 https://orcid.org/0000000241157376
- 700 1_
- $a Scadding, Glenis $u Royal National ENT Hospital, London and Division of Immunity and Infection, University College, London, UK
- 700 1_
- $a Senior, Brent $u Department of Otolaryngology/Head and Neck Surgery, University of North Carolina, Chapel Hill, North Carolina, USA
- 700 1_
- $a Tomazic, Peter Valentin $u Department of General Otorhinolaryngology, H&N Surgery, Medical University of Graz, Graz, Austria $1 https://orcid.org/0000000164454800
- 700 1_
- $a Toskala, Elina $u Otolaryngology-HNS, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
- 700 1_
- $a Van Zele, Thibaut $u Department of Otorhinolaryngology, Upper airways research laboratory, Ghent University, Ghent, Belgium
- 700 1_
- $a Viskens, An-Sofie $u Department of Microbiology and Immunology, Allergy and Clinical Immunology Research unit, KU Leuven, Leuven, Belgium $u Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium $1 https://orcid.org/0000000197577807
- 700 1_
- $a Wagenmann, Martin $u Department of Otorhinolaryngology, Universitätsklinikum Düsseldorf, Dusseldorf, Germany $1 https://orcid.org/0000000297340241
- 700 1_
- $a Fokkens, W J $u Department of Otorhinolaryngology, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands $1 https://orcid.org/000000034852229X
- 773 0_
- $w MED00009088 $t Allergy $x 1398-9995 $g Roč. 79, č. 5 (2024), s. 1123-1133
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38108602 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20241024114122 $b ABA008
- 999 __
- $a ok $b bmc $g 2143784 $s 1226067
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 79 $c 5 $d 1123-1133 $e 20231218 $i 1398-9995 $m Allergy $n Allergy $x MED00009088
- LZP __
- $a Pubmed-20240725
